• Explore /
  • Poster
  • / Role of killer cell immunoglobulin-like receptor (KIR)-ligand interactions to prevent relapse in patients (pts) receiving matched unrelated stem cell transplant (SCT) for acute myeloid leukemia (AML).

Role of killer cell immunoglobulin-like receptor (KIR)-ligand interactions to prevent relapse in patients (pts) receiving matched unrelated stem cell transplant (SCT) for acute myeloid leukemia (AML).

Abstract Poster

Authors

Hind Rafei

Hind Rafei

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Hind Rafei , Marcelo Fernández-Viña , Yudith Carmazzi , Brandt Moore , Dana Willis , Rafet Basar , Pinaki Prosad Banerjee , May Daher , Chitra Hosing , Partow Kebriaei , Issa F. Khouri , Rohtesh Mehta , Yago Nieto , Muzaffar H. Qazilbash , Elizabeth J. Shpall , Richard E. Champlin , David Marin , Katayoun Rezvani , Kai Cao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Allogenic Stem Cell Transplantation

Citation

J Clin Oncol 37, 2019 (suppl; abstr 7049)

DOI

10.1200/JCO.2019.37.15_suppl.7049

Abstract #

7049

Poster Bd #

424

Abstract Disclosures

Similar Posters

First Author: Jing Pan

First Author: Nicholas James Short

First Author: Wendy Stock

Poster

2018 ASCO Annual Meeting

Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.

Nivolumab (Nivo) maintenance (maint) in high-risk (HR) acute myeloid leukemia (AML) patients.

First Author: Tapan M. Kadia